Status:
COMPLETED
Post-operative CRP Trend After Ileocolic Resection in Crohn's Disease Patients.
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Crohn Disease
Eligibility:
All Genders
18+ years
Brief Summary
Our aim is to analyze C-Reactive Protein trends during the post-operative course in Crohn's Disease patients having undergone ileocolic resection and primary anastomosis, for the purpose of anastomoti...
Eligibility Criteria
Inclusion
- Crohn's disease patients
- Primary ileocolic anastomosis
- C-Reactive Protein data available in medical file
Exclusion
- Protective stoma
- Associated resection with or without anastomosis during intervention
Key Trial Info
Start Date :
January 27 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2021
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT04739579
Start Date
January 27 2021
End Date
March 1 2021
Last Update
July 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU de Nancy
Nancy, France